Blood Coagulation & Fibrinolysis

Papers
(The TQCC of Blood Coagulation & Fibrinolysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery50
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer17
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations16
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type13
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency13
Concurrent congenital hemophilia B and acquired hemophilia A: a unique case report13
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review10
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency10
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe9
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII9
Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre9
Characterization of antibody clones that bind exclusively to insoluble fibrin9
Harmonizing factor assay-related testing performed in a large laboratory network9
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy8
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation7
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study7
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians7
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada7
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination7
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose6
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score6
Efficacy and relative safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: a systematic review and meta-analysis6
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates6
Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia6
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays6
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans6
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT5
Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation5
Evaluation of the impact of changes in the autopsy rate on mortality trend of pulmonary embolism, Finland, 1996–20175
Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis5
A rare case of essential thrombocythemia with pseudo-hyperkalemia5
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests5
The link between high factor VIII to protein C ratio values and poor liver function after major hepatectomy5
Fibrinogen Aα gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients5
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients4
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience4
Endothelium-biomarkers for postthrombotic syndrome: a case–control study4
Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study4
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation4
Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding4
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing4
New treatments for primary immune thrombocytopenia4
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report4
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms4
Identification of two novel mutations in three children with congenital factor VII deficiency4
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?4
Two heterozygous mutations associated with type I protein C deficiency in two Chinese independent families4
Optimizing factor VIII dosing in obese individuals with haemophilia A4
Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage3
Protein S contributes to the paradoxical increase in thrombin generation by low-dose dabigatran in the presence of thrombomodulin3
Diagnosis of Immunoglobulin G4-related disease in a child with ligneous conjunctivitis: a novel mutation in plasminogen gene and plasminogen activator inhibitor-1 polymorphism3
Identification of a recurrent missense mutation in the FGA gene likely causing a congenital fibrinogen disorder3
New developments in the diagnosis of primary immune thrombocytopenia3
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection3
A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay3
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?3
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens3
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding3
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency3
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans3
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study3
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model3
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort3
Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease3
Multiple thrombotic sources and embolic events at arterial sites in a patient with protein-C deficiency3
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease3
A refugee child with multiple patterned ecchymoses: a diagnostic dilemma between nonaccidental injury and primary hemostatic defect3
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection3
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia3
Resolution of cardiac surgical bleeding with the combination of 4-factor prothrombin complex concentrate and fresh frozen plasma following lack of response to fresh frozen plasma alone in a patient wi3
Characteristics of factor V and protein C based on results from Korean testing centers2
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era2
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen2
Joint deficiency of coagulation factors VII and IX: a case report2
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream2
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays2
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome2
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency2
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene2
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient2
Addressing the haemophilia healthcare crisis amidst Taliban rule: a call to action2
Hemophilia in the south of Tunisia2
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding2
Clot waveform analysis in acute promyelocytic leukemia2
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays2
Real-world clinical outcomes with fostamatinib for the treatment of refractory chronic immune thrombocytopenia: a single-center experience2
The effect of tranexamic acid on myocardial injury in cardiac surgical patients: a systematic review and meta-analysis2
Reversal of life-threatening bleeding with protamine sulfate in a patient with plasma cell leukemia2
Uvaol alleviates oxidative stress induced human umbilical vein endothelial cell injury by suppressing mitogen-activated protein kinase signaling pathway2
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier2
Screening hemostatic defects in Saudi University students with unexplained menorrhagia: a diagnosis, which could be missed2
Self-limited thrombotic thrombocytopenic purpura2
Comment on: coagulopathy following Crotaline snakebites in northeast Florida2
Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders2
Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report2
Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients2
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey2
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities2
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study2
Inferior Vena Cava agenesis presenting as deep vein thrombosis in an eight year-old girl2
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment2
Clot waveform analysis in hemophilia carriers2
Obesity and physical exercise in hemophilia2
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia2
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system2
0.12004113197327